Cargando…
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation
Sorafenib is a first-line molecular-target drug for advanced hepatocellular carcinoma (HCC), but its clinical effects are still limited. In this study we identify Quiescin sulfhydryl oxidase 1 (QSOX1) acting as a cellular pro-oxidant, specifically in the context of sorafenib treatment of HCC. QSOX1...
Autores principales: | Sun, Jialei, Zhou, Chenhao, Zhao, Yue, Zhang, Xiaofei, Chen, Wanyong, Zhou, Qiang, Hu, Bo, Gao, Dongmei, Raatz, Lisa, Wang, Zhefang, Nelson, Peter J., Jiang, Yuchao, Ren, Ning, Bruns, Christiane J., Zhou, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024711/ https://www.ncbi.nlm.nih.gov/pubmed/33770521 http://dx.doi.org/10.1016/j.redox.2021.101942 |
Ejemplares similares
-
Quiescin-sulfhydryl oxidase inhibits prion formation in vitro
por: Zhan, Yi-An, et al.
Publicado: (2016) -
Diversification of Quiescin sulfhydryl oxidase in a preserved framework for redox relay
por: Limor-Waisberg, Keren, et al.
Publicado: (2013) -
Expression Level of Quiescin Sulfhydryl Oxidase 1 (Qsox1) in Neuroblastomas
por: Araújo, D.G.B., et al.
Publicado: (2014) -
Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis
por: Sung, Hye-Jin, et al.
Publicado: (2018) -
Secretory mouse quiescin sulfhydryl oxidase 1 aggregates defected human and mouse spermatozoa in vitro and in vivo
por: Wang, Tse-En, et al.
Publicado: (2021)